As of the first quarter of 2026, the wholesale acquisition cost of autoimmune disease drug Remicade was 1,168 U.S. dollars, compared to 946 U.S. dollars for the biosimilar Inflectra. Biosimilars of Remicade reduced costs by 19-59 percent.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Samsung Bioepis. (April 27, 2026). Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of the first quarter 2026 (in U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 15, 2026, from /statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Samsung Bioepis. "Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of the first quarter 2026 (in U.S. dollars)." Chart. April 27, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 15, 2026. /statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Samsung Bioepis. (2026). Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of the first quarter 2026 (in U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 15, 2026. /statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Samsung Bioepis. "Comparison of The Wholesale Acquisition Cost (Wac) of Remicade Vs Biosimilars in The United States as of The First Quarter 2026 (in U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 27 Apr 2026, /statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
Samsung Bioepis, Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of the first quarter 2026 (in U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/ (last visited July 15, 2026)
Comparison of the wholesale acquisition cost (WAC) of Remicade vs biosimilars in the United States as of the first quarter 2026 (in U.S. dollars) [Graph], Samsung Bioepis, April 27, 2026. [Online]. Available: /statistics/1186621/comparison-wac-remicade-vs-biosimilars-us/
